Increasing use of contralateral prophylactic mastectomy for breast cancer patients: a trend toward more aggressive surgical treatment
- PMID: 17954711
- DOI: 10.1200/JCO.2007.12.3141
Increasing use of contralateral prophylactic mastectomy for breast cancer patients: a trend toward more aggressive surgical treatment
Abstract
Purpose: Many patients with unilateral breast cancer choose contralateral prophylactic mastectomy to prevent cancer in the opposite breast. The purpose of our study was to determine the use and trends of contralateral prophylactic mastectomy in the United States.
Patients and methods: We used the Surveillance, Epidemiology and End Results database to review the treatment of patients with unilateral breast cancer diagnosed from 1998 through 2003. We determined the rate of contralateral prophylactic mastectomy as a proportion of all surgically treated patients and as a proportion of all mastectomies.
Results: We identified 152,755 patients with stage I, II, or III breast cancer; 4,969 patients chose contralateral prophylactic mastectomy. The rate was 3.3% for all surgically treated patients; 7.7%, for patients undergoing mastectomy. The overall rate significantly increased from 1.8% in 1998 to 4.5% in 2003. Likewise, the contralateral prophylactic mastectomy rate for patients undergoing mastectomy significantly increased from 4.2% in 1998 to 11.0% in 2003. These increased rates applied to all cancer stages and continued to the end of our study period. Young patient age, non-Hispanic white race, lobular histology, and previous cancer diagnosis were associated with significantly higher rates. Large tumor size was associated with a higher overall rate, but with a lower rate for patients undergoing mastectomy.
Conclusion: The use of contralateral prophylactic mastectomy in the United States more than doubled within the recent 6-year period of our study. Prospective studies are needed to understand the decision-making processes that have led to more aggressive breast cancer surgery.
Comment in
-
Contralateral prophylactic mastectomy: mind the genetics.J Clin Oncol. 2008 Apr 10;26(11):1909-10; author reply 1910. doi: 10.1200/JCO.2008.16.0275. J Clin Oncol. 2008. PMID: 18398162 No abstract available.
Similar articles
-
Increasing rates of contralateral prophylactic mastectomy among patients with ductal carcinoma in situ.J Clin Oncol. 2009 Mar 20;27(9):1362-7. doi: 10.1200/JCO.2008.20.1681. Epub 2009 Feb 17. J Clin Oncol. 2009. PMID: 19224844
-
Patient and surgeon characteristics associated with increased use of contralateral prophylactic mastectomy in patients with breast cancer.Ann Surg Oncol. 2009 Oct;16(10):2697-704. doi: 10.1245/s10434-009-0641-z. Epub 2009 Aug 4. Ann Surg Oncol. 2009. PMID: 19653045
-
Are mastectomy rates really increasing in the United States?J Clin Oncol. 2010 Jul 20;28(21):3437-41. doi: 10.1200/JCO.2009.27.6774. Epub 2010 Jun 14. J Clin Oncol. 2010. PMID: 20548000
-
Contralateral prophylactic mastectomy for patients with unilateral breast cancer.Expert Rev Anticancer Ther. 2007 Aug;7(8):1117-22. doi: 10.1586/14737140.7.8.1117. Expert Rev Anticancer Ther. 2007. PMID: 18028020 Review.
-
The contralateral prophylactic mastectomy decision-making process.Plast Surg Nurs. 2013 Jan-Mar;33(1):11-21; quiz 22-3. doi: 10.1097/PSN.0b013e3182842424. Plast Surg Nurs. 2013. PMID: 23446503 Review.
Cited by
-
Skin Flap Necrosis After Mastectomy With Reconstruction: A Prospective Study.Ann Surg Oncol. 2016 Jan;23(1):257-64. doi: 10.1245/s10434-015-4709-7. Epub 2015 Jul 21. Ann Surg Oncol. 2016. PMID: 26193963 Free PMC article.
-
Impact of Prophylactic Mastectomy in BRCA1/2 Mutation Carriers.Breast Care (Basel). 2014 Dec;9(6):385-9. doi: 10.1159/000369592. Breast Care (Basel). 2014. PMID: 25759620 Free PMC article. Review.
-
The role of tumor phenotype in the surgical treatment of early-stage breast cancer.Am J Surg. 2023 Jan;225(1):84-92. doi: 10.1016/j.amjsurg.2022.09.029. Epub 2022 Sep 22. Am J Surg. 2023. PMID: 36180300 Free PMC article.
-
Contralateral prophylactic mastectomy for unilateral breast cancer in Chinese female population: a retrospective cohort study.Gland Surg. 2023 Dec 26;12(12):1668-1685. doi: 10.21037/gs-23-384. Epub 2023 Dec 22. Gland Surg. 2023. PMID: 38229836 Free PMC article.
-
Defining the relationship between patient decisions to undergo breast reconstruction and contralateral prophylactic mastectomy.Plast Reconstr Surg. 2015 Mar;135(3):661-670. doi: 10.1097/PRS.0000000000001044. Plast Reconstr Surg. 2015. PMID: 25719688 Free PMC article.
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical